We’ve all had a moment where we arrived at the grocery store and can’t remember passing any of the stoplights along the way. We’re halfway down an aisle and scrambling to remember what we even needed. Our mind is in overdrive trying to sort through our ever-growing to-do list. We’ve been there when just making it through the next task is hard. But the normal stresses of life aren’t the only thing YOU have to deal with. Nora McInerny hosts The Head Start: Embracing the Journey, a new podcast ...
…
continue reading
Content provided by Audioboom and Not So Different: a Podcast from The Center for Biosimilars. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Not So Different: a Podcast from The Center for Biosimilars or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
S5 Ep12: Biosimilars Regulatory Roundup for November 2022—Podcast Edition
MP3•Episode home
Manage episode 348900991 series 2161808
Content provided by Audioboom and Not So Different: a Podcast from The Center for Biosimilars. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Not So Different: a Podcast from The Center for Biosimilars or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Show notes
Rezvoglar Becomes Second Interchangeable Insulin Biosimilar
Biosimilar Business Recap: Progress for Insulin in Europe, Canada; Biocon Biologics' Viatris Acquisition Completed
The European Union Gains Another Ranibizumab Biosimilar
Alvotech Snags Australian Approval for Adalimumab Biosimilar
Biosimilar Check-in: PBM to Cover Adalimumab Biosimilars; World’s First Denosumab Biosimilar; Organon Launches in Canada
Senator Introduces Bill to Rid Switching Study Requirements for Interchangeability
BioRationality: A Dr Sarfaraz Niazi Column—FDA Launches Biosimilar Regulatory Science Program
AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
Rezvoglar Becomes Second Interchangeable Insulin Biosimilar
Biosimilar Business Recap: Progress for Insulin in Europe, Canada; Biocon Biologics' Viatris Acquisition Completed
The European Union Gains Another Ranibizumab Biosimilar
Alvotech Snags Australian Approval for Adalimumab Biosimilar
Biosimilar Check-in: PBM to Cover Adalimumab Biosimilars; World’s First Denosumab Biosimilar; Organon Launches in Canada
Senator Introduces Bill to Rid Switching Study Requirements for Interchangeability
BioRationality: A Dr Sarfaraz Niazi Column—FDA Launches Biosimilar Regulatory Science Program
AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
156 episodes
MP3•Episode home
Manage episode 348900991 series 2161808
Content provided by Audioboom and Not So Different: a Podcast from The Center for Biosimilars. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Audioboom and Not So Different: a Podcast from The Center for Biosimilars or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Show notes
Rezvoglar Becomes Second Interchangeable Insulin Biosimilar
Biosimilar Business Recap: Progress for Insulin in Europe, Canada; Biocon Biologics' Viatris Acquisition Completed
The European Union Gains Another Ranibizumab Biosimilar
Alvotech Snags Australian Approval for Adalimumab Biosimilar
Biosimilar Check-in: PBM to Cover Adalimumab Biosimilars; World’s First Denosumab Biosimilar; Organon Launches in Canada
Senator Introduces Bill to Rid Switching Study Requirements for Interchangeability
BioRationality: A Dr Sarfaraz Niazi Column—FDA Launches Biosimilar Regulatory Science Program
AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
Rezvoglar Becomes Second Interchangeable Insulin Biosimilar
Biosimilar Business Recap: Progress for Insulin in Europe, Canada; Biocon Biologics' Viatris Acquisition Completed
The European Union Gains Another Ranibizumab Biosimilar
Alvotech Snags Australian Approval for Adalimumab Biosimilar
Biosimilar Check-in: PBM to Cover Adalimumab Biosimilars; World’s First Denosumab Biosimilar; Organon Launches in Canada
Senator Introduces Bill to Rid Switching Study Requirements for Interchangeability
BioRationality: A Dr Sarfaraz Niazi Column—FDA Launches Biosimilar Regulatory Science Program
AAM's Craig Burton: Is the Biden Administration Doing Enough to Help Biosimilars?
156 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.